We found relatively increased expression of Fap1 (Fas-associated phosphatase 1) in CML-LSCs, with consequent inhibition of Fas and Gsk3β [12–15]. The gene discussed is FAS; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.